Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

Page Options

Clinical Trial Questions?

Get Help:

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-5 of 5 for your search:

Drug:  c-Met inhibitor ARQ 197
Find trials that include:  Any drugs shown
Trial Status:  Closed

Help with Results

Select All on Page Sort by: Show Results per Page

A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-205, NCT00558207

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-209, NCT00777309

ARQ 197 in Subjects With Metastatic Solid Tumors

Phase: Phase I
Type: Tissue collection/Repository
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-101, NCT00302172

A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-103, NCT00612209

A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-111, NCT00612703

Select All on Page

Help with Results

| | | | | | | | |

A Service of the National Cancer Institute